Primary central nervus system lymphoma developing methotrexate pneumonitis due to high-dose treatment

Japanese Journal of Chemotherapy

Volumn 51, Issue 12, 2003, Pages 758-761

  Takei, Yutaka ^a   Usui, Noriko ^a   Hagino, Takeshi ^a   Okawa, Yutaka ^a   Sugiyama, Katsuki ^a   Uno, Shinji ^a   Dobashi, Nobuaki ^a   Kobayashi, Masayuki ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; METHYLPREDNISOLONE; PANIPENEM PLUS BETAMIPRON; PIPERACILLIN; STEROID;

ABNORMAL RESPIRATORY SOUND; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG PULSE THERAPY; DYSARTHRIA; DYSPNEA; FEVER; GAIT DISORDER; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; IMAGE ANALYSIS; LARGE CELL LYMPHOMA; LYMPHOCYTE TRANSFORMATION TEST; MALE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PNEUMONIA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; STEROID THERAPY; TUMOR BIOPSY; WHITE MATTER;

EID: 1642421918     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Maher E, Fine H: Primary CNS lymphoma. Semin Oncol.26: 346-356, 1999
2. Fine A, Mayer J: Primary central nervous system lymphoma. Ann Intern Med. 119: 1093-1104, 1993
3. Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. J Neurosurg. 65: 600-607, 1986
4. Lister A, Abrey L, Sandlund J: Central nervous system lymphoma. American society of hematology education program book. p. 283-296, 2002
5. Glass J, Gruber M L, Cher L, et al.: Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma, long-term outcome. J Neurosurg. 81: 188-195, 1994
6. Acute leukemia group B: Acute lymphocytic leukemia in children. Maintenance therapy methotrexate administerd intermittently. JAMA. 207: 923-928, 1969
7. Hilliquin P, Renoux M, Perrot S, et al.: Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis. Br J Rheumatol. 35: 441-445, 1996
8. Buchbinder R, Hall S, Sambrook P, et al.: Methotrexate therapy in rheumatoid arthritis, a life table review of 587 patients treated in community practice. J Rhuematol. 20: 639-644, 1993
9. Hargreaves M R, Mowat A, Benson M, et al.: Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis, report of five cases and review of published reports. Thorax. 47: 628-633, 1992
10. Alarcon G, Kremer J, Macaluso M, et al.: Risk factors for methotrexate-induced injury in patients with rheumatoid arthritis, a multicenter, case-control study.: Ann Intern Med. 127: 356-364, 1997.
11. Imokawa S, Colvy T, Leslie K, et al.: Methotrexate pneumonitis, review of the literature and histopathological findings in nine patients. Eur Respir J. 15: 373-381. 2000
12. Rosenow E, Myers J, Swensenn S, et al.: Drug-induced pulmonary disease. An update.Chest. 102: 239-250, 1992
13. Clarysse A, Cathey W, Cartwright G, et al.: Pulmonary disease complicating intermittent therapy with methotrexate. JAMA. 209: 1861-1864, 1969
14. Sostman H D, Matthay R, Putmann C, et al.: Methotrexate induced pneumonitis. Medicine. 55: 371-388, 1971